TA Associates looks to acquire stake in Synokem Pharma

By Debjyoti Roy

  • 18 Jan 2023
Premium
Credit: Thinkstock

Private equity firm TA Associates has emerged as the frontrunner to acquire a controlling stake in drugmaker Synokem Pharmaceuticals, two people aware of the development said. The US private equity fund is likely to invest around $100 million in Delhi-based Synokem, a contract manufacturer of pharmaceutical formulations such as tablets, capsules, ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.